SMO and cancer: To date, there is no evidence for the correlation between CK2 and Hh/Gli signaling in human cancer cells, although CK2 was suggested as a positive regulator of the Hh signal transduction pathway and two serine residues in Smo were phosphorylated by CK2 in Drosophila[43].